Differentiation of post streptococcal reactive arthritis from acute rheumatic fever
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Differentiation of post streptococcal reactive arthritis from acute rheumatic fever ; volume:6 ; number:1 ; day:15 ; month:9 ; year:2008 ; pages:1 ; date:9.2008
Pediatric rheumatology ; 6, Heft 1 (15.9.2008), 1, 9.2008
- Creator
-
Barash, J.
Mashihach, E.
Navon-Elkan, P.
Berkun, Y.
Harel, L.
Tauber, T.
Padeh, S.
Hashkes, PJ
Uziel, Y.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/1546-0096-6-S1-P198
- URN
-
urn:nbn:de:101:1-2019111722261407376449
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Barash, J.
- Mashihach, E.
- Navon-Elkan, P.
- Berkun, Y.
- Harel, L.
- Tauber, T.
- Padeh, S.
- Hashkes, PJ
- Uziel, Y.
- SpringerLink (Online service)
Other Objects (12)
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
MBL2 gene polymorphism rs1800450 and rheumatic fever with and without rheumatic heart disease: an Egyptian pilot study
Post-streptococcal reactive arthritis in children: a distinct entity from acute rheumatic fever
The effect of group A streptococcal carrier on the epidemic model of acute rheumatic fever
Pathology and therapy of rheumatic fever
Understanding group A streptococcal pharyngitis and skin infections as causes of rheumatic fever: protocol for a prospective disease incidence study
Immunopathology of rheumatic fever and rheumatoid arthritis
Cardiac magnetic resonance in acute rheumatic fever
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations
A community-based program to reduce acute rheumatic fever and rheumatic heart disease in northern Australia
Secondary prophylaxis in rheumatic fever: is it time to change?
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease